SIRT2 and breast cancer: The TM pseudopeptide demonstrated cytotoxic effects in multiple breast cancer cell lines but had less impact on the growth of normal epithelial cell lines, indicating that breast cancer cells are more susceptible to Sirt2 inhibition [186].